[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Preclinical CRO Market: Global Market Size, Forecast, Insights, and Competitive Landscape

November 2022 | 118 pages | ID: P6AFCBFCF556EN
Prodture

US$ 2,299.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global preclinical CRO market is expected to grow at a CAGR of around 9.9% during 2023-2030. This report on global preclinical CRO market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global preclinical CRO market by segmenting the market based on service, end-use, and region. Also, detailed profiles of companies operating in the preclinical CRO market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
  • Rising Number of Drugs in Preclinical Trials
  • Growing Outsourcing R&D Activities
  • Increasing R&D Expenditure Worldwide
Market Challenges
  • Stringent Regulatory Policies
Historical & Forecast Period

Base Year: 2022

Historical Period: 2018-2022

Forecast Period: 2023-2030

Market by Service
  • Bioanalysis and DMPK Studies
        • In vitro ADME
        • In-vivo PK
  • Toxicology Testing
    • GLP
    • Non-GLP
  • Compound Management
    • Process R&D
    • Custom Synthesis
    • Others
  • Chemistry
    • Medicinal Chemistry
    • Computation Chemistry
  • Safety Pharmacology
  • Others
Market by End Use
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies
Market by Region
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Rest of Europe
  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • United Arab Emirates
    • Rest of Middle East & Africa
1. PREFACE

1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
  1.4.1 Phase I
  1.4.2 Phase II
  1.4.3 Phase III
1.5 Assumptions

2. KEY INSIGHTS

3. GLOBAL PRECLINICAL CRO MARKET

3.1. Introduction
3.2. Market Drives
3.3. Market Challenges

4. GLOBAL PRECLINICAL CRO MARKET ANALYSIS

4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. GLOBAL PRECLINICAL CRO MARKET BY SERVICE

5.1. Introduction
5.2. Bioanalysis and DMPK Studies
  5.2.1. In vitro ADME
  5.2.2. In-vivo PK
5.3. Toxicology Testing
  5.3.1. GLP
  5.3.2. Non-GLP
5.4. Compound Management
  5.4.1. Process R&D
  5.4.2. Custom Synthesis
  5.4.3. Others
5.5. Chemistry
  5.5.1. Medicinal Chemistry
  5.5.2. Computation Chemistry
5.6. Safety Pharmacology
5.7. Others

6. GLOBAL PRECLINICAL CRO MARKET BY END USE

6.1. Introduction
6.2. Biopharmaceutical Companies
6.3. Government and Academic Institutes
6.4. Medical Device Companies

7. GLOBAL PRECLINICAL CRO MARKET BY REGION

7.1. Introduction
7.2. Europe
  7.2.1. Germany
  7.2.2. United Kingdom
  7.2.3. France
  7.2.4. Italy
  7.2.5. Spain
  7.2.6. Russia
  7.2.7. Netherlands
  7.2.8. Rest of the Europe
7.3. North America
  7.3.1. United States
  7.3.2. Canada
7.4. Asia Pacific
  7.4.1. China
  7.4.2. Japan
  7.4.3. India
  7.4.4. South Korea
  7.4.5. Australia
  7.4.6. Indonesia
  7.4.7. Rest of the Asia Pacific
7.5. Latin America
  7.5.1. Mexico
  7.5.2. Brazil
  7.5.3. Argentina
  7.5.4. Rest of Latin America
7.6. Middle East & Africa
  7.6.1. Saudi Arabia
  7.6.2. Turkey
  7.6.3. Iran
  7.6.4. United Arab Emirates
  7.6.5. Rest of Middle East & Africa

8. SWOT ANALYSIS

9. PORTER’S FIVE FORCES

10. MARKET VALUE CHAIN ANALYSIS

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Company Profiles
  11.2.1. Charles River Laboratories Inc.
  11.2.2. Covance Inc. (Laboratory Corporation of America Holdings)
  11.2.3. Envigo Corp.
  11.2.4. Eurofins Scientific
  11.2.5. ICON Plc
  11.2.6. MD Biosciences Inc. (MLM Medical Labs)
  11.2.7. Medpace
  11.2.8. Parexel International Corporation
  11.2.9. PPD Inc.
  11.2.10. Wuxi AppTec


LIST OF TABLES

Table 1: Global Preclinical CRO Market Portraiture
Table 2: Global Preclinical CRO Market by Service (in US$ Million), 2022 & 2030
Table 3: Global Preclinical CRO Market by End Use (in US$ Million), 2022 & 2030
Table 4: Global Preclinical CRO Market by Region (in US$ Million), 2022 & 2030
Table 5: Europe Preclinical CRO Market by Country (in US$ Million), 2022 & 2030
Table 6: North America Preclinical CRO Market by Country (in US$ Million), 2022 & 2030
Table 7: Asia Pacific Preclinical CRO Market by Country (in US$ Million), 2022 & 2030
Table 8: Latin America Preclinical CRO Market by Country (in US$ Million), 2022 & 2030
Table 9: Middle East & Africa Preclinical CRO Market by Country (in US$ Million), 2022 & 2030
Table 10: List of Key Players


LIST OF FIGURES

Figure 1: Global Preclinical CRO Market (in US$ Million), 2018-2022
Figure 2: Global Preclinical CRO Market by Service, 2022
Figure 3: Global Preclinical CRO Market by End Use, 2022
Figure 4: Global Preclinical CRO Market by Region, 2022
Figure 5: Global Preclinical CRO Market (in US$ Million), 2023-2030
Figure 6: Global Preclinical CRO Market by Service (in %), 2022 & 2030
Figure 7: Global Bioanalysis and DMPK Studies Preclinical CRO Market (in US$ Million), 2018-2022
Figure 8: Global Bioanalysis and DMPK Studies Preclinical CRO Market (in US$ Million), 2023-2030
Figure 9: Global In vitro ADME Bioanalysis and DMPK Studies Preclinical CRO Market (in US$ Million), 2018-2030
Figure 10: Global In-vivo PK ADME Bioanalysis and DMPK Studies Preclinical CRO Market (in US$ Million), 2018-2030
Figure 11: Global Toxicology Testing Preclinical CRO Market (in US$ Million), 2018-2022
Figure 12: Global Toxicology Testing Preclinical CRO Market (in US$ Million), 2023-2030
Figure 13: Global GLP Toxicology Testing Preclinical CRO Market (in US$ Million), 2018-2030
Figure 14: Global Non-GLP Toxicology Testing Preclinical CRO Market (in US$ Million), 2018-2030
Figure 15: Global Compound Management Preclinical CRO Market (in US$ Million), 2018-2022
Figure 16: Global Compound Management Preclinical CRO Market (in US$ Million), 2023-2030
Figure 17: Global Process R&D Compound Management Preclinical CRO Market (in US$ Million), 2018-2030
Figure 18: Global Custom Synthesis Compound Management Preclinical CRO Market (in US$ Million), 2018-2030
Figure 19: Global Others Compound Management Preclinical CRO Market (in US$ Million), 2018-2030
Figure 20: Global Chemistry Preclinical CRO Market (in US$ Million), 2018-2022
Figure 21: Global Chemistry Preclinical CRO Market (in US$ Million), 2023-2030
Figure 22: Global Medicinal Chemistry Preclinical CRO Market (in US$ Million), 2018-2030
Figure 23: Global Computation Chemistry Preclinical CRO Market (in US$ Million), 2018-2030
Figure 24: Global Safety Pharmacology Preclinical CRO Market (in US$ Million), 2018-2022
Figure 25: Global Safety Pharmacology Preclinical CRO Market (in US$ Million), 2023-2030
Figure 26: Global Other Services Preclinical CRO Market (in US$ Million), 2018-2022
Figure 27: Global Other Services Pharmacology Preclinical CRO Market (in US$ Million), 2023-2030
Figure 28: Global Preclinical CRO Market by End Use (in %), 2022 & 2030
Figure 29: Global Biopharmaceutical Companies Preclinical CRO Market (in US$ Million), 2018-2022
Figure 30: Global Biopharmaceutical Companies Preclinical CRO Market (in US$ Million), 2023-2030
Figure 31: Global Government and Academic Institutes Preclinical CRO Market (in US$ Million), 2018-2022
Figure 32: Global Government and Academic Institutes Preclinical CRO Market (in US$ Million), 2023-2030
Figure 33: Global Medical Device Companies Preclinical CRO Market (in US$ Million), 2018-2022
Figure 34: Global Medical Device Companies Preclinical CRO Market (in US$ Million), 2023-2030
Figure 35: Global Preclinical CRO Market by Region (in %), 2022 & 2030
Figure 36: Europe Preclinical CRO Market (in US$ Million), 2018-2022
Figure 37: Europe Preclinical CRO Market (in US$ Million), 2023-2030
Figure 38: Europe Preclinical CRO Market by Country (in %), 2022 & 2030
Figure 39: Germany Preclinical CRO Market (in US$ Million), 2018-2030
Figure 40: United Kingdom Preclinical CRO Market (in US$ Million), 2018-2030
Figure 41: France Preclinical CRO Market (in US$ Million), 2018-2030
Figure 42: Italy Preclinical CRO Market (in US$ Million), 2018-2030
Figure 43: Spain Preclinical CRO Market (in US$ Million), 2018-2030
Figure 44: Russia Preclinical CRO Market (in US$ Million), 2018-2030
Figure 45: Netherlands Preclinical CRO Market (in US$ Million), 2018-2030
Figure 46: Rest of Europe Preclinical CRO Market (in US$ Million), 2018-2030
Figure 47: North America Preclinical CRO Market (in US$ Million), 2018-2022
Figure 48: North America Preclinical CRO Market (in US$ Million), 2023-2030
Figure 49: North America Preclinical CRO Market by Country (in %), 2022 & 2030
Figure 50: United States Preclinical CRO Market (in US$ Million), 2018-2030
Figure 51: Canada Preclinical CRO Market (in US$ Million), 2018-2030
Figure 52: Asia Pacific Preclinical CRO Market (in US$ Million), 2018-2022
Figure 53: Asia Pacific Preclinical CRO Market (in US$ Million), 2023-2030
Figure 54: Asia Pacific Preclinical CRO Market by Country (in %), 2022 & 2030
Figure 55: China Preclinical CRO Market (in US$ Million), 2018-2030
Figure 56: Japan Preclinical CRO Market (in US$ Million), 2018-2030
Figure 57: India Preclinical CRO Market (in US$ Million), 2018-2030
Figure 58: South Korea Preclinical CRO Market (in US$ Million), 2018-2030
Figure 59: Australia Preclinical CRO Market (in US$ Million), 2018-2030
Figure 60: Indonesia Preclinical CRO Market (in US$ Million), 2018-2030
Figure 61: Rest of Asia Pacific Preclinical CRO Market (in US$ Million), 2018-2030
Figure 62: Latin America Preclinical CRO Market (in US$ Million), 2018-2022
Figure 63: Latin America Preclinical CRO Market (in US$ Million), 2023-2030
Figure 64: Latin America Preclinical CRO Market by Country (in %), 2022 & 2030
Figure 65: Mexico Preclinical CRO Market (in US$ Million), 2018-2030
Figure 66: Brazil Preclinical CRO Market (in US$ Million), 2018-2030
Figure 67: Argentina Preclinical CRO Market (in US$ Million), 2018-2030
Figure 68: Rest of Latin America Preclinical CRO Market (in US$ Million), 2018-2030
Figure 69: Middle East & Africa Preclinical CRO Market (in US$ Million), 2018-2022
Figure 70: Middle East & Africa Preclinical CRO Market (in US$ Million), 2023-2030
Figure 71: Middle East & Africa Preclinical CRO Market by Country (in %), 2022 & 2030
Figure 72: Saudi Arabia Preclinical CRO Market (in US$ Million), 2018-2030
Figure 73: Turkey Preclinical CRO Market (in US$ Million), 2018-2030
Figure 74: Iran Preclinical CRO Market (in US$ Million), 2018-2030
Figure 75: UAE Preclinical CRO Market (in US$ Million), 2018-2030
Figure 76: Rest of Middle East and Africa Preclinical CRO Market (in US$ Million), 2018-2030
Figure 77: Market Value Chain


More Publications